Ensign Group Reports 18% Q2 Revenue, Adds 52 Facilities

The Ensign Group reported strong financial results for the second quarter of 2025, with revenue reaching $1.23 billion, an 18.5% increase year-over-year, and GAAP diluted earnings per share rising 18.0% to $1.44. The company's same-facility occupancy rate hit a record 82.1%, and transitioning facilities reached 84.0%, reflecting significant operational improvements and strong clinical outcomes. Ensign expanded its portfolio by acquiring 52 new facilities since early 2024, growing to 348 healthcare operations across 17 states, and maintained robust liquidity with $364 million in cash and $592.6 million in available credit. The company raised its full-year 2025 guidance, projecting earnings per share between $6.34 and $6.46 and revenues between $4.99 billion and $5.02 billion, signaling confidence in continued growth. Ensign's strong financial health and positive analyst outlook, with an average target price implying over 15% upside, further underscore its solid market position. The company hosted a webcast to discuss these results, providing insights into ongoing strategic initiatives and operational execution.